ArriVent BioPharma Inc. C... (AVBP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
25.27
0.42 (1.69%)
At close: Jan 15, 2025, 1:47 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 |
Cash & Equivalents | 150.39M | 163.37M | 37.28M |
Short-Term Investments | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 2.00K |
Other Long-Term Assets | 2.84M | 72.00K | 87.00K |
Receivables | 761.00K | 500.00K | 250.00K |
Inventory | -240.00K | n/a | n/a |
Other Current Assets | 9.06M | 156.00K | 29.00K |
Total Current Assets | 159.97M | 182.62M | 42.95M |
Property-Plant & Equipment | 291.00K | 139.00K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a |
Total Long-Term Assets | 3.13M | 211.00K | 89.00K |
Total Assets | 163.10M | 182.83M | 43.04M |
Account Payables | 4.53M | 3.09M | 293.00K |
Deferred Revenue | n/a | -1 | n/a |
Short-Term Debt | 140.00K | 128.00K | n/a |
Other Current Liabilities | 6.95M | 5.14M | 1.52M |
Total Current Liabilities | 11.62M | 8.36M | 1.82M |
Long-Term Debt | 177.00K | 11.00K | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a |
Total Long-Term Liabilities | 177.00K | 11.00K | n/a |
Total Liabilities | 11.80M | 8.37M | 1.82M |
Total Debt | 317.00K | 139.00K | n/a |
Common Stock | n/a | 4.00K | 4.00K |
Retained Earnings | -157.84M | -88.51M | -51.61M |
Comprehensive Income | n/a | -4.00K | -4.00K |
Shareholders Equity | 151.30M | 174.46M | 41.22M |
Total Investments | n/a | n/a | 2.00K |